EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Estimating magnetic resonance imaging proton density fat fraction from ultrasound attenuation and clinical parameters in pediatric hepatic steatosis: development of a prediction model

Shin Hye Hwang, Sejin Jeong, Dong-Kyu Kim, Seungsoo Lee, Soo Yoon Chung, Seok-Jae Heo, Gyeonghyun Cho, Kyungchul Song, Byung Won Yoo, Eun Byoul Lee, Hyun Joo Shin

Ultrasonography · 2026-11-01 · 45 (6) · 618-628

DOI: 10.14366/usg.26201 ↗
AbstractBibliografische Angaben

Abstract

Purpose: This study evaluated the diagnostic performance of the ultrasound-guided attenuation parameter (UGAP) for pediatric hepatic steatosis and developed a multivariable model to estimate magnetic resonance imaging proton density fat fraction (MRI-PDFF) from ultrasound and clinical variables.Methods: This single-center retrospective study included pediatric patients who underwent UGAP measurement and MRI-PDFF assessment within 3 months of each other. UGAP performance in detecting moderate-to-severe (≥S2) and severe (S3) steatosis was evaluated using the area under the receiver operating characteristic curve (AUC). Multivariable models were developed using linear regression and a random forest algorithm with five-fold cross-validation.Results: Among 45 patients (33 male and 12 female; median age, 12 years), median UGAP and MRI-PDFF values were 0.83 dB/cm/MHz and 22%, respectively. UGAP correlated moderately with MRI-PDFF (ρ=0.596, P<0.001). The AUC was 0.74 for both ≥S2 and S3 steatosis (95% confidence intervals [CIs], 0.58 to 0.91 and 0.60 to 0.89, respectively), and two discordant cases were identified. A model incorporating UGAP, age, height, and liver size outperformed UGAP alone in detecting ≥S2 steatosis (optimism-corrected AUC, 0.882 vs. 0.744; P=0.01). In the machine learning analysis, the model showed stable performance during cross-validation, with an AUC of 0.789 (95% CI, 0.649 to 0.928) for ≥S2 steatosis and an R² of 0.663 for continuous MRI-PDFF prediction.Conclusion: UGAP correlated moderately with MRI-PDFF and showed fair performance in grading pediatric hepatic steatosis. Combining UGAP with clinical parameters significantly improved MRI-PDFF estimation, providing a practical screening tool for hepatic steatosis when MRI is unavailable. External validation is needed.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →